A citation-based method for searching scientific literature

Cinnamon S Bloss, Burcu F Darst, Eric J Topol, Nicholas J Schork. Hum Mol Genet 2011
Times Cited: 61

List of co-cited articles
380 articles co-cited >1

Times Cited
  Times     Co-cited

Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.
Saskia C Sanderson, Suzanne C O'Neill, Della Brown White, Gerold Bepler, Lori Bastian, Isaac M Lipkus, Colleen M McBride. Cancer Epidemiol Biomarkers Prev 2009

An integrated map of genetic variation from 1,092 human genomes.
Goncalo R Abecasis, Adam Auton, Lisa D Brooks, Mark A DePristo, Richard M Durbin, Robert E Handsaker, Hyun Min Kang, Gabor T Marth, Gil A McVean. Nature 2012

Disclosure of APOE genotype for risk of Alzheimer's disease.
Robert C Green, J Scott Roberts, L Adrienne Cupples, Norman R Relkin, Peter J Whitehouse, Tamsen Brown, Susan LaRusse Eckert, Melissa Butson, A Dessa Sadovnick, Kimberly A Quaid,[...]. N Engl J Med 2009

Communicating genetic risk information for common disorders in the era of genomic medicine.
Denise M Lautenbach, Kurt D Christensen, Jeffrey A Sparks, Robert C Green. Annu Rev Genomics Hum Genet 2013

Delivery of genomic medicine for common chronic adult diseases: a systematic review.
Maren T Scheuner, Pauline Sieverding, Paul G Shekelle. JAMA 2008

Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing.
Deanna Alexis Carere, Peter Kraft, Kimberly A Kaphingst, J Scott Roberts, Robert C Green. Genet Med 2016

How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study.
Jenny E Ostergren, Michele C Gornick, Deanna Alexis Carere, Sarah S Kalia, Wendy R Uhlmann, Mack T Ruffin, Joanna L Mountain, Robert C Green, J Scott Roberts. Public Health Genomics 2015

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.
Cathelijne H van der Wouden, Deanna Alexis Carere, Anke H Maitland-van der Zee, Mack T Ruffin, J Scott Roberts, Robert C Green. Ann Intern Med 2016

The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease.
A C J W Janssens, A A M Wilde, I M van Langen. Neth Heart J 2011

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
Timothy M Frayling, Nicholas J Timpson, Michael N Weedon, Eleftheria Zeggini, Rachel M Freathy, Cecilia M Lindgren, John R B Perry, Katherine S Elliott, Hana Lango, Nigel W Rayner,[...]. Science 2007

Letting the genome out of the bottle--will we get our wish?
David J Hunter, Muin J Khoury, Jeffrey M Drazen. N Engl J Med 2008

Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.
Colleen M McBride, Sharon Hensley Alford, Robert J Reid, Eric B Larson, Andreas D Baxevanis, Lawrence C Brody. Genet Med 2009

ASHG Statement* on direct-to-consumer genetic testing in the United States.
Kathy Hudson, Gail Javitt, Wylie Burke, Peter Byers. Obstet Gynecol 2007

Evaluation of risk prediction updates from commercial genome-wide scans.
Raluca Mihaescu, Mandy van Hoek, Eric J G Sijbrands, André G Uitterlinden, Jacqueline C M Witteman, Albert Hofman, Cornelia M van Duijn, A Cecile J W Janssens. Genet Med 2009

The path to personalized medicine.
Margaret A Hamburg, Francis S Collins. N Engl J Med 2010

Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006.
Katrina A B Goddard, Debra Duquette, Amy Zlot, Jenny Johnson, Ann Annis-Emeott, Patrick W Lee, Mary Pat Bland, Karen L Edwards, Kristin Oehlke, Rebecca T Giles,[...]. Am J Public Health 2009

Genetic risk estimation in the Coriell Personalized Medicine Collaborative.
Catharine B Stack, Neda Gharani, Erynn S Gordon, Tara Schmidlen, Michael F Christman, Margaret A Keller. Genet Med 2011

Direct-to-consumer genetic testing: good, bad or benign?
T Caulfield, N M Ries, P N Ray, C Shuman, B Wilson. Clin Genet 2010

Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change.
C Lerman, K Gold, J Audrain, T H Lin, N R Boyd, C T Orleans, B Wilfond, G Louben, N Caporaso. Health Psychol 1997

Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial.
Theresa Marteau, Victoria Senior, Steve E Humphries, Martin Bobrow, Treena Cranston, Martin A Crook, Lorna Day, Maryam Fernandez, Rob Horne, Andrew Iversen,[...]. Am J Med Genet A 2004

Direct-to-consumer testing: more risks than opportunities.
G Lippi, E J Favaloro, M Plebani. Int J Clin Pract 2011

Improving validation practices in "omics" research.
John P A Ioannidis, Muin J Khoury. Science 2011

Population screening in the age of genomic medicine.
Muin J Khoury, Linda L McCabe, Edward R B McCabe. N Engl J Med 2003

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
Hayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, Anne Y Warren, Johanna Burge, Anne George, Elizabeth Bancroft, Sameer Jhavar, Daniel Leongamornlert, Malgorzata Tymrakiewicz,[...]. PLoS One 2010

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Jonas Hugosson, Sigrid Carlsson, Gunnar Aus, Svante Bergdahl, Ali Khatami, Pär Lodding, Carl-Gustaf Pihl, Johan Stranne, Erik Holmberg, Hans Lilja. Lancet Oncol 2010

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Rosalind A Eeles, Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, Michelle Guy, Gianluca Severi, Kenneth Muir, John L Hopper, Brian E Henderson, Christopher A Haiman,[...]. Nat Genet 2009

Multiple loci identified in a genome-wide association study of prostate cancer.
Gilles Thomas, Kevin B Jacobs, Meredith Yeager, Peter Kraft, Sholom Wacholder, Nick Orr, Kai Yu, Nilanjan Chatterjee, Robert Welch, Amy Hutchinson,[...]. Nat Genet 2008

Screening and prostate-cancer mortality in a randomized European study.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa,[...]. N Engl J Med 2009

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.
Robert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, Gianluca Severi, Ali Amin Al Olama, Lesley McGuffog, Zsofia Kote-Jarai, Michelle Guy, Lynne T O'Brien, Amanda L Hall,[...]. Genet Epidemiol 2011

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Mark J Rieder, Alexander P Reiner, Brian F Gage, Deborah A Nickerson, Charles S Eby, Howard L McLeod, David K Blough, Kenneth E Thummel, David L Veenstra, Allan E Rettie. N Engl J Med 2005

Evaluating the utility of personal genomic information.
Morris W Foster, John J Mulvihill, Richard R Sharp. Genet Med 2009

Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic.
Katherine M James, Clayton T Cowl, Jon C Tilburt, Pamela S Sinicrope, Marguerite E Robinson, Katrin R Frimannsdottir, Kristina Tiedje, Barbara A Koenig. Mayo Clin Proc 2011

Principles for the post-GWAS functional characterization of cancer risk loci.
Matthew L Freedman, Alvaro N A Monteiro, Simon A Gayther, Gerhard A Coetzee, Angela Risch, Christoph Plass, Graham Casey, Mariella De Biasi, Chris Carlson, David Duggan,[...]. Nat Genet 2011

Prediction of individual genetic risk to disease from genome-wide association studies.
Naomi R Wray, Michael E Goddard, Peter M Visscher. Genome Res 2007

Genotype score in addition to common risk factors for prediction of type 2 diabetes.
James B Meigs, Peter Shrader, Lisa M Sullivan, Jarred B McAteer, Caroline S Fox, Josée Dupuis, Alisa K Manning, Jose C Florez, Peter W F Wilson, Ralph B D'Agostino,[...]. N Engl J Med 2008

The predictive capacity of personal genome sequencing.
Nicholas J Roberts, Joshua T Vogelstein, Giovanni Parmigiani, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu. Sci Transl Med 2012

Health behavior change: can genomics improve behavioral adherence?
Colleen M McBride, Angela D Bryan, Molly S Bray, Gary E Swan, Eric D Green. Am J Public Health 2012

Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.
Flavia M Facio, Haley Eidem, Tyler Fisher, Stephanie Brooks, Amy Linn, Kimberly A Kaphingst, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2013

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
J A Johnson, L Gong, M Whirl-Carrillo, B F Gage, S A Scott, C M Stein, J L Anderson, S E Kimmel, M T M Lee, M Pirmohamed,[...]. Clin Pharmacol Ther 2011

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.